Brussels’ beleaguered coronavirus vaccination program could be poised to get a shot in the arm as the #EU’s central regulator completes its initial stage in appraising #SputnikV, the #vaccine developed by Moscow’s Gamaleya Center.
The European Medicines Agency (EMA) told Russian media on Tuesday that the scientific consultation process was now finalized. “As a next step, the company can prepare an application for a registration certificate” for the EU market, a source at the agency informed RIA Novosti.
Later that morning, the Russian Direct Investment Fund (RDIF), which financed the development of the formula, announced that it “has official confirmation from the EMA that the application was accepted.” How quickly it could receive final approval to be used is now up to the regulator.
Follow us on Telegram https://t.me/rtintl